Resurgent Financial Advisors »

United Therapeutics Corporation shares owned by Resurgent Financial Advisors

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Resurgent Financial Advisors from 13F filings

Historical chart of Resurgent Financial Advisors investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Resurgent Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Resurgent Financial Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $401k 677 592.98
2022-12-31 $213k 764 278.09
2022-09-30 $201k 961 209.16
2022-06-30 $239k 1.0k 235.24

More positions owned by Resurgent Financial Advisors

Alphabet Cap Stk Cl A (GOOGL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Johnson & Johnson (JNJ)
Vanguard Specialized Funds Div App Etf (VIG)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Exxon Mobil Corporation (XOM)
Texas Pacific Land Corp (TPL)
Amazon (AMZN)

View all positions for Resurgent Financial Advisors

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Wellington Management Company
Vanguard Portfolio Management
Vanguard Capital Management
Renaissance Technologies
State Street Corporation
Geode Capital Management
Henderson Group
AQR Capital Management
Citadel Advisors
Assetmark
Invesco
Dimensional Fund Advisors

View all funds holding United Therapeutics Corporation